Ausgabe 4/2003
Inhalt (16 Artikel)
Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis
Alexandra Giatromanolaki, Efthimios Sivridis, Efstratios Maltezos, Nick Athanassou, Dimitrios Papazoglou, Kevin C Gatter, Adrian L Harris, Michael I Koukourakis
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
Meliha Crnkic, Bengt Månsson, Lotta Larsson, Pierre Geborek, Dick Heinegård, Tore Saxne
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1
Helena Forsblad d'Elia, Lars-Åke Mattsson, Claes Ohlsson, Elisabeth Nordborg, Hans Carlsten
Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6
Astrid Kehlen, A Pachnio, K Thiele, J Langner
The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis
Andrzej Pawlik, Lidia Ostanek, Iwona Brzosko, Marek Brzosko, Marek Masiuk, Boguslaw Machalinski, Barbara Gawronska-Szklarz
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus
Martin Aringer, Josef S Smolen
SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus
Karen H Costenbader, Matthew H Liang
DEK binding to class II MHC Y-box sequences is gene- and allele-specific
Barbara S Adams, Hyuk C Cha, Joanne Cleary, Tan Haiying, Hongling Wang, Kajal Sitwala, David M Markovitz
Regulation and localization of endogenous human tristetraprolin
Anna-Marie Fairhurst, John E Connolly, Katharine A Hintz, Nicolas J Goulding, Athos J Rassias, Mark P Yeager, William Rigby, Paul K Wallace
The use and abuse of commercial kits used to detect autoantibodies
Marvin J Fritzler, Allan Wiik, Mark L Fritzler, Susan G Barr